Australia markets open in 9 hours 6 minutes

ImmuCell Corporation (ICCC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.030.00 (0.00%)
As of 04:00PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 39.06M
Enterprise value 54.78M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.23
Price/book (mrq)1.56
Enterprise value/revenue 3.14
Enterprise value/EBITDA -21.25

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 32.03%
S&P500 52-week change 323.06%
52-week high 36.05
52-week low 34.26
50-day moving average 35.16
200-day moving average 35.04

Share statistics

Avg vol (3-month) 37.31k
Avg vol (10-day) 39.85k
Shares outstanding 57.75M
Implied shares outstanding 67.75M
Float 85.58M
% held by insiders 128.04%
% held by institutions 113.49%
Shares short (28 Mar 2024) 46.12k
Short ratio (28 Mar 2024) 40.94
Short % of float (28 Mar 2024) 40.10%
Short % of shares outstanding (28 Mar 2024) 40.08%
Shares short (prior month 29 Feb 2024) 46.32k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 325 July 1990

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -33.05%
Operating margin (ttm)-9.35%

Management effectiveness

Return on assets (ttm)-7.36%
Return on equity (ttm)-20.86%

Income statement

Revenue (ttm)17.47M
Revenue per share (ttm)2.26
Quarterly revenue growth (yoy)30.30%
Gross profit (ttm)N/A
EBITDA -2.5M
Net income avi to common (ttm)-5.77M
Diluted EPS (ttm)-0.75
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)978.74k
Total cash per share (mrq)0.13
Total debt (mrq)16.69M
Total debt/equity (mrq)66.78%
Current ratio (mrq)2.73
Book value per share (mrq)3.22

Cash flow statement

Operating cash flow (ttm)-4.67M
Levered free cash flow (ttm)-4.51M